Biotech

All Articles

Novartis pens $150M in advance bispecifics deal with Dren Bio

.Novartis has had some misfortune with bispecific antibodies in the past, yet determining due to the...

AstraZeneca plants an EGFR plant along with Pinetree deal worth $45M

.Pinetree Therapeutics will certainly aid AstraZeneca plant some trees in its own pipeline along wit...

GRO collects $60M series B to take gout pain treatment right into clinic

.GRO Biosciences has actually finished the full week along with an additional $60.3 million in the b...

Chutes &amp Ladders-- Gilead's Merdad Parsey goes, Cassava sheds CEO

.Invite to this week's Chutes &amp Ladders, our summary of substantial management hirings, shootings...